| 000 | 01320 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514025130.0 | ||
| 264 | 0 | _c20020529 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a1170-7690 | ||
| 024 | 7 |
_a10.2165/00019053-200220020-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKarnon, Jonathan | |
| 245 | 0 | 0 |
_aTamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation. _h[electronic resource] |
| 260 |
_bPharmacoEconomics _c2002 |
||
| 300 |
_a119-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticarcinogenic Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aTamoxifen _xadverse effects |
| 700 | 1 | _aBrown, Jackie | |
| 773 | 0 |
_tPharmacoEconomics _gvol. 20 _gno. 2 _gp. 119-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00019053-200220020-00005 _zAvailable from publisher's website |
| 999 |
_c11794997 _d11794997 |
||